Tempus AI Inc. to Report Q2 2024 Financial Results on August 6
2 Sources
2 Sources
[1]
Tempus to Report Second Quarter 2024 Financial Results on August 6
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the second quarter on Tuesday, August 6, 2024. The company will hold the second quarter 2024 earnings conference call at 4:30 p.m. ET. The company's quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
[2]
Tempus to Report Second Quarter 2024 Financial Results on August 6 By Investing.com
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the second quarter on Tuesday, August 6, 2024. The company will hold the second quarter 2024 earnings conference call at 4:30 p.m. ET. The company's quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers (NYSE:ROG). The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Share
Share
Copy Link
Tempus AI Inc., a leading AI-driven precision medicine company, has announced that it will release its second quarter 2024 financial results on August 6, 2023. The company will also host a conference call to discuss the results and provide a business update.
Upcoming Financial Report
Tempus AI Inc., a prominent artificial intelligence-driven precision medicine company, has announced its plans to release the financial results for the second quarter of 2024 on Sunday, August 6, 2023
1
2
. This announcement has caught the attention of investors and industry analysts alike, as it provides an opportunity to gauge the company's performance and future prospects.Conference Call Details
In conjunction with the release of the financial results, Tempus will be hosting a conference call and live audio webcast
1
. The call is scheduled to take place on Monday, August 7, 2023, at 8:00 a.m. Eastern Time (ET)2
. This timing allows investors and interested parties to review the results before the market opens, potentially influencing trading decisions for the day.Accessing the Conference Call
For those interested in participating in the conference call, Tempus has provided multiple ways to access the event:
- Toll-Free Dial-In: 1-877-704-4453
- International Dial-In: 1-201-389-0920
- Conference ID: 13739753
1
2
These options ensure that both domestic and international participants can easily join the call and stay informed about the company's performance.
Webcast Information
For those who prefer a visual component or cannot join via phone, Tempus will also be providing a live audio webcast of the conference call
1
. The webcast will be accessible through the company's investor relations website at investors.tempus.com, under the "Events and Presentations" section2
.Related Stories
Replay Availability
Understanding that not all interested parties may be able to join the live call, Tempus has arranged for a replay of the conference call to be available. The replay can be accessed by calling 1-844-512-2921 (US) or 1-412-317-6671 (International) and using the replay pin number 13739753
1
2
. This replay will be available until August 14, 2023, at 11:59 p.m. ET, giving ample time for review.Significance of the Announcement
This announcement is significant for several reasons:
- It demonstrates Tempus's commitment to transparency and regular communication with its investors and the public.
- The financial results will provide insights into the company's performance in the rapidly evolving field of AI-driven precision medicine.
- The conference call offers an opportunity for analysts and investors to ask questions directly to the management team, potentially revealing more about the company's strategies and future outlook.
As the date approaches, market watchers will be keen to see how Tempus AI Inc. has performed in the second quarter and what this might indicate about the broader AI and healthcare technology sectors.
References
Summarized by
Navi
[1]
Related Stories
Tempus AI Reports Strong Q4 2024 Results, Showcasing Growth in AI-Driven Healthcare
25 Feb 2025•Business and Economy
Tempus AI Reports Strong Q2 2025 Results, Driven by AI-Powered Genomics and Data Services
08 Aug 2025•Business and Economy
Tempus AI Stock Soars on Collaboration with Follicular Lymphoma Institute, Attracts Major Institutional Investors
14 Feb 2025•Technology
Weekly Highlights
1
Anthropic Secures $13B in Funding, Reaching $183B Valuation Amid AI Industry Boom
Business and Economy
2
OpenAI Partners with Broadcom to Develop Custom AI Chips, Challenging Nvidia's Dominance
Technology
3
Tesla Proposes $1 Trillion Pay Package for Elon Musk, Tied to Ambitious AI and Robotics Goals
Business and Economy
Weekly Highlights
Explore today's top stories
Your Daily Dose of Curated AI News
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.
